Theleme Partners’s Equifax EFX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$91.1M Buy
574,213
+33,125
+6% +$5.65M 5.41% 7
2026
Q1
$97.4M Buy
541,088
+35,000
+7% +$6.95M 6.49% 7
2025
Q4
$110M Hold
506,088
7.15% 8
2025
Q3
$130M Sell
506,088
-92,000
-15% -$23.1M 8.3% 7
2025
Q2
$155M Hold
598,088
9.43% 8
2025
Q1
$146M Sell
598,088
-115,000
-16% -$28.9M 11.45% 5
2024
Q4
$182M Buy
713,088
+115,000
+19% +$30.8M 12.18% 5
2024
Q3
$176M Buy
598,088
+207,000
+53% +$58.4M 10.05% 4
2024
Q2
$94.8M Buy
+391,088
New +$93.3M 4.55% 7

Other funds holding EFX

Theleme Partners's EFX Position: Q2 2026 in Review

Theleme Partners increased its Equifax (EFX) stake by 6.1% in Q2 2026, buying an estimated $5.65M and bringing the position to 574,213 shares worth $91.1M. The position accounts for 5.41% of the portfolio, ranked #7.

Theleme Partners first reported a position in EFX in Q2 2024 and has held it in 9 quarters since. The position peaked at $182M in Q4 2024. 835 funds tracked by Wall St. Rank hold EFX as of Q2 2026.

  • Theleme Partners held 574,213 shares of Equifax worth $91.1M as of Q2 2026.
  • Theleme Partners bought 33,125 Equifax shares in Q2 2026, an estimated $5.65M.
  • Equifax made up 5.41% of Theleme Partners's portfolio in Q2 2026, its #7 holding.
  • Theleme Partners first reported a position in Equifax in Q2 2024 and has held it in 9 quarters since.
  • Theleme Partners's Equifax position peaked at $182M in Q4 2024.
  • 835 funds tracked by Wall St. Rank held Equifax as of Q2 2026.

Based on Theleme Partners's 13F filing for Q2 2026, filed 13 Aug 2026.